158 related articles for article (PubMed ID: 2689016)
1. Adjuvant therapy of bullous pemphigoid with dapsone.
Jeffes EW; Ahmed AR
Clin Exp Dermatol; 1989 Mar; 14(2):132-6. PubMed ID: 2689016
[TBL] [Abstract][Full Text] [Related]
2. Dapsone as first line therapy for bullous pemphigoid.
Venning VA; Millard PR; Wojnarowska F
Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
[TBL] [Abstract][Full Text] [Related]
3. [Bullous pemphigoid: a review].
Bernard P; Charneux J
Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
[TBL] [Abstract][Full Text] [Related]
4. Dapsone for the treatment of bullous pemphigoid.
Piamphongsant T
Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.
Tirado-Sánchez A; Díaz-Molina V; Ponce-Olivera RM
Allergol Immunopathol (Madr); 2012; 40(3):152-5. PubMed ID: 21497011
[TBL] [Abstract][Full Text] [Related]
6. An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Sticherling M; Franke A; Aberer E; Gläser R; Hertl M; Pfeiffer C; Rzany B; Schneider S; Shimanovich I; Werfel T; Wilczek A; Zillikens D; Schmidt E
Br J Dermatol; 2017 Nov; 177(5):1299-1305. PubMed ID: 28494097
[TBL] [Abstract][Full Text] [Related]
7. Dapsone and sulfapyridine therapy of pemphigoid diseases.
Rogers RS
Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
[No Abstract] [Full Text] [Related]
8. Lack of predictive factors for the clinical course of bullous pemphigoid.
Venning VA; Wojnarowska F
J Am Acad Dermatol; 1992 Apr; 26(4):585-9. PubMed ID: 1597545
[TBL] [Abstract][Full Text] [Related]
9. Interventions for bullous pemphigoid.
Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of pemphigus and pemphigoid].
Schaumburg-Lever G
Z Hautkr; 1986 Jun; 61(11):811-2. PubMed ID: 3526731
[TBL] [Abstract][Full Text] [Related]
11. Interventions for bullous pemphigoid.
Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
Cochrane Database Syst Rev; 2005 Jul; (3):CD002292. PubMed ID: 16034874
[TBL] [Abstract][Full Text] [Related]
12. Dapsone--other indications.
Barranco VP
Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
[No Abstract] [Full Text] [Related]
13. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Gürcan HM; Ahmed AR
Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
[TBL] [Abstract][Full Text] [Related]
15. High-dose methylprednisolone in the treatment of bullous pemphigoid.
Siegel J; Eaglstein WH
Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
Seminario-Vidal L; Sami N; Miller J; Theos A
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
[TBL] [Abstract][Full Text] [Related]
17. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
Piamphongsant T
Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
[No Abstract] [Full Text] [Related]
18. Bullous pemphigoid in adolescence.
Patsatsi A; Kyriakou A; Werth VP
Pediatr Dermatol; 2019 Mar; 36(2):184-188. PubMed ID: 30569520
[TBL] [Abstract][Full Text] [Related]
19. Bullous lichen planus: diagnosis by indirect immunofluorescence and treatment with dapsone.
Camisa C; Neff JC; Rossana C; Barrett JL
J Am Acad Dermatol; 1986 Mar; 14(3):464-9. PubMed ID: 3514699
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of treatments for bullous pemphigoid.
Khumalo NP; Murrell DF; Wojnarowska F; Kirtschig G
Arch Dermatol; 2002 Mar; 138(3):385-9. PubMed ID: 11902990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
